Atticus Wealth Management, LLC Axsome Therapeutics, Inc. Transaction History

Atticus Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$69.25 - $82.21 $346 - $411	-5 Reduced 25.0%	15 $1,000
Q1 2023 Apr 17, 2023	SELL	$58.39 - $75.0 $58,390 - $75,000	-1,000 Reduced 98.04%	20 $1,000
Q4 2022 Jan 31, 2023	SELL	$39.94 - $79.72 $3,195 - $6,377	-80 Reduced 7.27%	1,020 $78,000
Q2 2022 Jul 13, 2022	SELL	$21.74 - $46.75 $2,174 - $4,675	-100 Reduced 8.33%	1,100 $42,000
Q1 2022 Apr 15, 2022	BUY	$23.7 - $41.39 $7,110 - $12,417	300 Added 33.33%	1,200 $50,000
Q3 2021 Oct 18, 2021	BUY	$19.91 - $68.26 $17,919 - $61,434	900 New	900 $30,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Atticus Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Atticus Wealth Management, LLC with notifications on news.